In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue growth over the past decade.

Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...

In this article we are going to estimate the intrinsic value of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by taking the expected future cash flows and discounting them to their present value.

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Google has made Gemini 2.0 "generally available" through the Gemini API in Google AI Studio and Vertex AI, marking a ...

Google’s Gemini 2.0 is here, bringing improved performance, smarter reasoning, and new models like Flash-Lite and Pro for ...

Google DeepMind has made available Gemini 2.0 Flash and introduced new models, including Gemini 2.0 Pro Experimental and ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Busy day at Google today: the company rolled out version 2.0 of its Gemini AI assistant (previously announced in December) ...

Gemini 2.0 Flash is the base model that powers the free version of Gemini. It replaces Gemini 1.5 Flash which was released ...